UY31283A1 - Intermediarios y métodos de preparacion de ésteres de derivados sustituidos del acido carboxilico 4-(2-oxo-1,2,4,5-tetrahidro-1,3-benzoldiazepina-3yl)-piperidina-1, sales farmacéuticamente aceptadas, isomeros, - Google Patents

Intermediarios y métodos de preparacion de ésteres de derivados sustituidos del acido carboxilico 4-(2-oxo-1,2,4,5-tetrahidro-1,3-benzoldiazepina-3yl)-piperidina-1, sales farmacéuticamente aceptadas, isomeros,

Info

Publication number
UY31283A1
UY31283A1 UY31283A UY31283A UY31283A1 UY 31283 A1 UY31283 A1 UY 31283A1 UY 31283 A UY31283 A UY 31283A UY 31283 A UY31283 A UY 31283A UY 31283 A1 UY31283 A1 UY 31283A1
Authority
UY
Uruguay
Prior art keywords
benzoldiazepina
piperidina
tetrahidro
esteres
iss
Prior art date
Application number
UY31283A
Other languages
English (en)
Inventor
Andreass Zopf
Werner Rall
Uwe Joerg Ries
Kathrin Maier
Michael Konrad
Guenther Huchler
Stefan Goepper
Kathrin Pachur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31283A1 publication Critical patent/UY31283A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Es objeto de la presente invencion un procedimiento para preparar compuestos de formula general I en la que R1.1, R1.2, R1.3 y R2 se definen como se menciona en la descripcion, sus sales de tolerancia farmacéutica y sus solvatos, que se pueden preparar a partir de compuestos de la formula general II en la que R1.1, R1.2 y R1.3 se definen como se menciona en la descripcion.
UY31283A 2007-08-13 2008-08-11 Intermediarios y métodos de preparacion de ésteres de derivados sustituidos del acido carboxilico 4-(2-oxo-1,2,4,5-tetrahidro-1,3-benzoldiazepina-3yl)-piperidina-1, sales farmacéuticamente aceptadas, isomeros, UY31283A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007038250A DE102007038250A1 (de) 2007-08-13 2007-08-13 Neues Herstellverfahren

Publications (1)

Publication Number Publication Date
UY31283A1 true UY31283A1 (es) 2009-03-31

Family

ID=39877761

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31283A UY31283A1 (es) 2007-08-13 2008-08-11 Intermediarios y métodos de preparacion de ésteres de derivados sustituidos del acido carboxilico 4-(2-oxo-1,2,4,5-tetrahidro-1,3-benzoldiazepina-3yl)-piperidina-1, sales farmacéuticamente aceptadas, isomeros,

Country Status (16)

Country Link
US (1) US8222402B2 (es)
EP (1) EP2195294A1 (es)
JP (1) JP2010535837A (es)
KR (1) KR20100053651A (es)
CN (1) CN101821237A (es)
AR (1) AR068806A1 (es)
AU (1) AU2008288429A1 (es)
BR (1) BRPI0815498A2 (es)
CA (1) CA2696205A1 (es)
CL (1) CL2008002376A1 (es)
DE (1) DE102007038250A1 (es)
MX (1) MX2010001600A (es)
PE (1) PE20090901A1 (es)
TW (1) TW200916461A (es)
UY (1) UY31283A1 (es)
WO (1) WO2009021942A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221996B (es) * 1991-11-14 1994-04-01 Glaxo Group Ltd
US5883102A (en) * 1995-10-17 1999-03-16 Astra Pharmaceuticals Limited Pharmaceutically active compounds
TR199801254T2 (xx) 1995-12-29 1998-10-21 Smithkline Beecham Corporation Vitronektin resept�r� antagonistleri.
DE10250080A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004015723A1 (de) * 2004-03-29 2005-10-20 Boehringer Ingelheim Pharma Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004018795A1 (de) 2004-04-15 2005-10-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
EP1770091A1 (de) * 2005-09-29 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co. KG CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102005038831A1 (de) * 2005-08-17 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102007038251A1 (de) * 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren

Also Published As

Publication number Publication date
EP2195294A1 (de) 2010-06-16
CA2696205A1 (en) 2009-02-19
WO2009021942A1 (de) 2009-02-19
JP2010535837A (ja) 2010-11-25
AR068806A1 (es) 2009-12-09
PE20090901A1 (es) 2009-08-06
TW200916461A (en) 2009-04-16
AU2008288429A1 (en) 2009-02-19
DE102007038250A1 (de) 2009-02-19
CN101821237A (zh) 2010-09-01
MX2010001600A (es) 2010-03-15
US8222402B2 (en) 2012-07-17
CL2008002376A1 (es) 2009-09-11
BRPI0815498A2 (pt) 2015-02-10
US20110071286A1 (en) 2011-03-24
KR20100053651A (ko) 2010-05-20

Similar Documents

Publication Publication Date Title
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
DOP2014000203A (es) Compuestos de heterociclilo
BR112015000106A2 (pt) moduladores heterocíclicos de síntes de lipídio
CO6620050A2 (es) Derivados de aminopirimidina como moduladores de la lrrk2
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
NZ601483A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX348606B (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 de repeticion rica en leucina (lrrk2).
CO7131360A2 (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
NI201200061A (es) Derivados de quinazolina-4(3h)-ona utilizados como inhibidores de la cinasa de pi3
CR11793A (es) 2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas
BR112012029647A2 (pt) novos derivados de pirimidinas
MX2013001614A (es) Compuestos heterociclico.
CY1115043T1 (el) Φαρμακευτικο σκευασμα
CL2012000708A1 (es) Compuestos derivados de imidazopiridina o imidazopirimidina, inhibidores de pde10a; proceso de preparacion de dichos compuestos; composiciones farmaceuticas; y su uso para el tratamiento terapeutico y/o preventivo de trastornos psicoticos, esquizofrenia, enfermedad de alzheimer, tumores solidos, entre otras enfermedades.
MY155230A (en) Sulfoximine-substituted aniline pyrimidine derivatives as cdk inhibitors, their manufacture and use as medicine
CO6361924A2 (es) Nuevas lactamas como inhibidores de beta secretasa
MX338551B (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
DOP2016000276A (es) 2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BR112013030264A2 (pt) ácidos acéticos de benzociclohepteno
BR112015010136A2 (pt) derivados de oxazolidin-2-ona-pirimidina
UY30851A1 (es) Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos
UY31282A1 (es) Intermediarios y métodos de preparacion de ésteres de derivados sustituidos del acido carboxilico 4-(2-oxo-1,2,4,5-tetrahidro-1,3-benzoldiazepina-3yl)-piperidina-1, sales farmacéuticamente aceptadas, isomeros,

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20171011